eVTOL trading on June 5 separated the group by what investors trust most right now. Joby Aviation closed at $11.12 on 23,592,526 shares, Archer Aviation closed at $6.38 on 57,115,584 shares, and EHang closed at $9.78 on 1,025,828 shares. Macro context also stayed relevant: the U.S. 10-year Treasury yield was 4.47% and the effective fed funds rate was 3.63%, which still keeps pressure on long-duration eVTOL valuations even when company-specific milestones improve.
For today’s detailed market data, see Joby Daily, Archer Daily, and EHang Daily.
Is Joby’s infrastructure push telling us commercialization is closer than the FAA tracker can confirm?
Joby gave the market a useful tension point today: the company is still described in supplied reporting as being in Stage 4 of the FAA’s five-stage type-certification process, yet its operating footprint is already being built as if post-certification execution matters just as much as the certification milestone itself. The most concrete new data point was the purchase of a 47,500-square-foot testing facility near Hollister Municipal Airport for about $15 million, as reported by Zag Daily. That move sits alongside Joby’s broader manufacturing push in Dayton, where reporting tied the company to a 700,000-square-foot facility and a target of producing four aircraft per month in 2027. When I line those figures up, I do not read them as random expansion. I read them as management trying to remove the next bottleneck before the current bottleneck is fully cleared.
That matters because eVTOL valuation is no longer only a science-project valuation. The companies that win this phase will be the ones that can convert certification progress into repeatable aircraft output, route launches, and fleet reliability without losing a year to unprepared infrastructure. Joby’s capital allocation looks designed around that exact transition. The company also exited the first quarter with $874.52 million of cash and cash equivalents and $701.05 million of long-term debt, according to the supplied daily inputs and follow-on earnings coverage from Yahoo Finance. That balance-sheet picture is not effortless, but it is large enough that a $15 million facility purchase does not look reckless on its own. It looks like a measured pre-revenue bet that test capacity and production readiness are now worth paying for.
The counterargument is that investors still do not have a fresh FAA database confirmation from this run. FAA certification data was unavailable this run; next check scheduled for 2026-06-06. That gap matters because if Stage 5 takes longer than external reporting suggests, the infrastructure story can shift from disciplined preparation to premature spend very quickly. The same logic applies if Dayton capacity ramps more slowly than planned. Aerospace history is full of companies that spent correctly in concept but too early in calendar time.
My read is constructive. The way I see it, Joby is acting like commercialization risk is starting to migrate from “can we certify?” toward “can we operate at scale once certified?” I think that is the right risk to prepare for if management really believes Stage 5 is near, and the supplied evidence supports that interpretation more than a skeptical one. The directional lean here is constructive, but not carefree: I would stay constructive only as long as new infrastructure is paired with visible certification movement and not treated as a substitute for it.
Is Archer getting too much credit for liquidity while the market underprices its public proof gap?
Archer still has one of the strongest balance-sheet narratives in the sector, and the market continues to reward it for that. The supplied daily materials showed about $1.8 billion of liquidity, a current ratio of 18.06, completion of FAA Type Certification Phase 3, and Phase 4 in progress. ARKX also held Archer at about 4.12% of the ETF, equal to 6,653,156 shares as of June 3, while Joby’s weight was about 3.01%, or 2,760,003 shares. That relative allocation matters because it says sophisticated thematic capital still prefers Archer more aggressively than Joby on a flow basis. Add in Archer’s $6.38 close on 57,115,584 shares and you get a stock that remains liquid, watched, and very much inside the institutional conversation.
But liquidity is not the same thing as technical closure. Archer’s biggest valuation vulnerability is that the market is still granting it a premium for future operating proof that is not yet as public or as vivid as some investors pretend. Archer’s own investor-relations update on first-quarter 2026 results emphasized certification progress and the expectation for initial U.S. operations in 2026, which keeps the story alive and important through the company’s IR channel. Yet the same cross-sector data set highlighted a sharper proof point elsewhere: Vertical Aerospace said it completed a piloted thrustborne-to-wingborne transition on April 2 under UK Civil Aviation Authority oversight and paired that disclosure with financing support of up to $850 million, according to the company release carried by Stock Titan. That is not a narrative milestone. That is a technical demonstration milestone.
I think investors are still being a little too forgiving about that gap. Archer can absolutely argue that its cash position, certification sequencing, and partner ecosystem buy it time. It can also argue that being in Phase 4 keeps it on a credible runway toward service. Those are fair points. Still, if another eVTOL name has already shown a piloted transition and attached a fresh financing package to that show of proof, then Archer’s valuation should face a tougher burden of comparison than it often does in day-to-day trading. The market is acting as if capital certainty alone can cover for a missing public demonstration threshold, and I am not sure that assumption will hold indefinitely.
My view is cautious rather than bearish. I do not think Archer is weak; I think it is well-funded and still strategically live. My read, though, is that the stock earns a more cautious lean until it closes the public proof gap with a milestone investors can point to without interpretation. The directional lean here is cautious: cash and certification progress deserve credit, but not enough credit to erase the difference between promised performance and demonstrated performance.
Did UBS force EHang’s valuation back into line, or is the certification premium still too high?
EHang was the clearest analyst-action story in the sector today, and the numbers were blunt. UBS cut the stock to Neutral from Buy and lowered its price target from $21.00 to $11.10, a 47.1% reduction. The same downgrade package also cut its 2025 revenue forecast by 18%, lowered 2026 through 2028 shipment and revenue expectations by 50% to 70%, and pushed breakeven out to 2029 or 2030, as summarized by GuruFocus and echoed across the raw feed. That is not a cosmetic target cut. It is a reset of the commercialization curve. Even after that, the supplied daily files still placed EHang at roughly $700.1 million of market capitalization with a price-to-sales ratio of 11.56. Those numbers are why the valuation debate still matters.
The bull case is not imaginary. EHang already holds meaningful Chinese certification advantages, and that matters because certification is still the biggest gating event for many peers. A company that has moved through that gate should trade at some premium to companies that are still describing what approval might look like. But I think the downgrade usefully exposed the next problem: certification does not automatically create fast commercialization, especially when deployment still depends on city-level approvals, operating permissions, and the pace at which actual deliveries translate into repeatable revenue. UBS was effectively saying that the bottleneck has shifted downstream. If that is right, then investors should stop valuing EHang as though regulatory success already guarantees near-term scale.
Peer comparison sharpens that conclusion. Joby’s premium is increasingly tied to infrastructure and production readiness, while Archer’s premium is tied to liquidity and certification runway. EHang’s premium, by contrast, now rests more heavily on the argument that first-mover certification in China can still outrun slower commercialization assumptions. I think that argument has weakened. EHang closed at $9.78 on only 1,025,828 shares, far lighter activity than Archer or Joby, and that lower volume can amplify sharp narrative repricing when analyst targets move. The market may still admire the certification lead, but admiration is not the same thing as a justified double-digit sales multiple after multi-year estimates have been cut so aggressively.
My view is skeptical on valuation, even if not dismissive on the company’s long-term place in the sector. The way I see it, UBS did not fully remove the certification premium; it only challenged it. Until EHang proves that certification converts into faster deployment than UBS now expects, the directional lean remains skeptical. I think the stock can stabilize, but the available data still suggests investors are paying too much for a commercialization path that just got materially marked down.
What to Watch Tomorrow
- Watch whether Joby pairs its expanded test footprint with any dated evidence that the move from FAA Stage 4 toward Stage 5 is advancing on schedule.
- Watch whether Archer produces a public technical milestone strong enough to narrow the gap between its liquidity story and the harder proof already shown by Vertical.
- Watch whether EHang answers the UBS downgrade with any operating or regulatory signal that directly challenges the newly lowered shipment and revenue path.
This is not financial advice. Do your own research.
Follow @futurewatchlog for daily eVTOL coverage.
Previous insight: https://futurewatchlog.com/2026/06/04/evtol-daily-insight-2026-06-04/